DDInter178 DDInter160
Bendamustine is a nitrogen mustard drug indicated for use in the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen. Bendamustine is a bifunctional mechlorethamine derivative capable of forming electrophilic alkyl groups that covalently bond to other molecules. Through this function as an alkylating agent, bendamustine causes intra- and inter-strand crosslinks between DNA bases resulting in cell death. It is active against both active and quiescent cells, although the exact mechanism of action is unknown.
Bacillus calmette-guerin substrain tice live antigen is a vaccine containing attenuated live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of *Mycobacterium bovis* for percutaneous use. It is administered to prevent the development of tuberculosis.
Bacillus calmette-guerin substrain tice live antigen {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Budesonide
Bacillus calmette-guerin substrain tice live antigen {u} may lead to a major life threatening interaction when taken with {v} Etanercept
Bacillus calmette-guerin substrain tice live antigen {u} may lead to a major life threatening interaction when taken with {v} Ocrelizumab
Bacillus calmette-guerin substrain tice live antigen may cause a moderate interaction that could exacerbate diseases when taken with Budesonide
Bacillus calmette-guerin substrain tice live antigen may lead to a major life threatening interaction when taken with Etanercept
Bacillus calmette-guerin substrain tice live antigen may lead to a major life threatening interaction when taken with Ocrelizumab